Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in understanding the mechanisms of resistance to BCL-2 inhibitors
Yilan Xu, Haige Ye
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
Jiaxuan Xu, Xiaoqing Dong, David C.S. Huang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4957-4957
Open Access | Times Cited: 22
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
Digant Nayak, Dongwen Lv, Yaxia Yuan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects
Ya-ruo Lei, Xian-lu He, Jun Li, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2, pp. 52-52
Open Access | Times Cited: 9
Venetoclax Resistance in Acute Myeloid Leukemia
Sylvain Garciaz, Marie‐Anne Hospital, Yves Collette, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 9
The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
Xin Zhang, Suwen Chen, Guoliang Yin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics (2024) Vol. 29
Open Access | Times Cited: 8
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
Gus O. Nwosu, David M. Ross, Jason A. Powell, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 8
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeonjin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 7
Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival
Nicolas Rosa, Femke Speelman-Rooms, Jan B. Parys, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188791-188791
Open Access | Times Cited: 26
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Mariam Markouli, Maria Pagoni, Panagiotis Diamantopoulos
Frontiers in Oncology (2025) Vol. 14
Open Access
The mitochondrial protease ClpP is a promising target for multiple myeloma treatment
Xiang Liu, Jinlong Gu, Song Liu, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116855-116855
Closed Access
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy
James T. Hagen, McLane M. Montgomery, Raphael Taiwo Aruleba, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
Bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via AKT signaling pathway
Zhansheng Zhu, Shanwen Liang, Hong Yu, et al.
Aging (2024)
Open Access | Times Cited: 4
Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy
An-Bu Liu, Jia Liu, Sheng Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
Keli Lima, Diego A. Pereira‐Martins, Lívia Bassani Lins de Miranda, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 18
Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries
Mi Tian, Lei Mao, Li Zhang
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 16
Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia
Carlos Rodríguez‐Medina, Ruth Stuckey, Cristina Bilbao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1421-1421
Open Access | Times Cited: 3
Genetic mutations affecting mitochondrial function in cancer drug resistance
Chanhaeng Lee, Sanghee Park, Sungjoo Kim Yoon
Genes & Genomics (2023) Vol. 45, Iss. 3, pp. 261-270
Open Access | Times Cited: 8
CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia
Xinting Hu, Yang Han, Jiarui Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies
David W. Woolston, Nathan D. Lee, Mazyar Shadman, et al.
Haematologica (2023)
Open Access | Times Cited: 8
AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens
Szymon Milnerowicz, Julia Maszewska, Paulina Skowera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15849-15849
Open Access | Times Cited: 7
Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
Jiong Li, Xiangjun Ma, Faying Xu, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 314-325
Open Access | Times Cited: 2
CXCR4-Mediated Codelivery of FLT3 and BCL-2 Inhibitors for Enhanced Targeted Combination Therapy of FLT3-ITD Acute Myeloid Leukemia
Jiakun Yang, Peng Zhang, Yumin Mao, et al.
Biomacromolecules (2024) Vol. 25, Iss. 7, pp. 4569-4580
Closed Access | Times Cited: 2
Dexamethasone enhances venetoclax-induced apoptosis in acute myeloid leukemia cells
Haixia Wang, Junjie Zhou, Xiaoyu Ma, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 5
Prognostic Analysis of Lactic Acid Metabolism Genes in Oral Squamous Cell Carcinoma
Shiying Shen, Hongrong Zhang, Yemei Qian, et al.
International Dental Journal (2024) Vol. 74, Iss. 5, pp. 1053-1063
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top